Beta-blockers for congestive heart failure.

Controversies in the use of beta blockers in heart failure.

Recent evidence from randomized controlled trials has provided compelling evidence to support the use of beta blockers in most patients with heart failure due to systolic dysfunction. There is little disagreement about the mortality benefit provided by adding beta blockers to standard therapy, which may include angiotensin-converting enzyme inhibitors, diuretics, and sometimes digoxin. A few ar...

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

PURPOSE Congestive heart failure is an important cause of patient morbidity and mortality. Although several randomized clinical trials have compared beta-blockers with placebo for treatment of congestive heart failure, a meta-analysis quantifying the effect on mortality and morbidity has not been performed recently. DATA SOURCES The MEDLINE, Cochrane, and Web of Science electronic databases w...

Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen

Congestive heart failure has been associated with high morbidity and mortality requiring hospitalisation and is further complicated by noncompliance and under prescriptions. We aim to determine medication adherence and percentage deviation among Asians population in general and Yemenis in particular. A cross-sectional, prospective observational study with purposive sampling was conducted at two...

Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry.

INTRODUCTION AND OBJECTIVES To compare acute myocardial infarction patients with or without congestive heart failure in the French FAST-MI registry. METHODS The French FAST-MI registry included 374 centers and 3059 patients over a 1-month period at the end of 2005, with 1-year follow-up. Among this population, patients with at least one congestive heart failure criterion constituted group 1 (...

Beta-Blockers in Congestive Heart Failure: the Evolution of a New Treatment Concept - Mechanisms of Action and Clinical Implications